Vitamin B6 resensitizes mcr-carrying Gram-negative bacteria to colistin

Abstract Antimicrobial resistance poses a severe threat to human health, with colistin serving as a critical medication in clinical trials against multidrug-resistant Gram-negative bacteria. However, the efficacy of colistin is increasingly compromised due to the rise of MCR-positive bacteria worldw...

Full description

Saved in:
Bibliographic Details
Main Authors: Tianqi Xu, Dan Fang, Fulei Li, Zhiqiang Wang, Yuan Liu
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-025-07911-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849390255425191936
author Tianqi Xu
Dan Fang
Fulei Li
Zhiqiang Wang
Yuan Liu
author_facet Tianqi Xu
Dan Fang
Fulei Li
Zhiqiang Wang
Yuan Liu
author_sort Tianqi Xu
collection DOAJ
description Abstract Antimicrobial resistance poses a severe threat to human health, with colistin serving as a critical medication in clinical trials against multidrug-resistant Gram-negative bacteria. However, the efficacy of colistin is increasingly compromised due to the rise of MCR-positive bacteria worldwide. Here, we reveal a notable metabolic disparity between mcr-positive and -negative bacteria through transcriptome and metabolomics analysis. Specifically, pyridoxal 5’-phosphate (PLP), the active form of vitamin B6, was significantly diminished in mcr-positive bacteria. Conversely, supplementing with PLP could reverse the metabolic profile of drug-resistant bacteria and effectively restore colistin’s bactericidal properties. Mechanistically, PLP was found to augment bacterial proton motive force by inhibiting the Kdp transport system, a bacterial K+ transport ATPase, thereby facilitating the binding of the positively charged colistin to the negatively charged bacterial membrane components. Furthermore, PLP supplementation triggers ferroptosis-like death by accumulating ferrous ions and inducing lipid peroxidation. These two modes of action collectively resensitize mcr-harboring Gram-negative bacteria to colistin therapy. Altogether, our study provides a novel metabolic-driven antibiotic sensitization strategy to tackle antibiotic resistance and identifies a potentially safe antibiotic synergist.
format Article
id doaj-art-5aea0a5896f64f5cbe0f87fdccc18f1f
institution Kabale University
issn 2399-3642
language English
publishDate 2025-03-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj-art-5aea0a5896f64f5cbe0f87fdccc18f1f2025-08-20T03:41:43ZengNature PortfolioCommunications Biology2399-36422025-03-018111410.1038/s42003-025-07911-5Vitamin B6 resensitizes mcr-carrying Gram-negative bacteria to colistinTianqi Xu0Dan Fang1Fulei Li2Zhiqiang Wang3Yuan Liu4Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou UniversityJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou UniversityJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou UniversityJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou UniversityJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou UniversityAbstract Antimicrobial resistance poses a severe threat to human health, with colistin serving as a critical medication in clinical trials against multidrug-resistant Gram-negative bacteria. However, the efficacy of colistin is increasingly compromised due to the rise of MCR-positive bacteria worldwide. Here, we reveal a notable metabolic disparity between mcr-positive and -negative bacteria through transcriptome and metabolomics analysis. Specifically, pyridoxal 5’-phosphate (PLP), the active form of vitamin B6, was significantly diminished in mcr-positive bacteria. Conversely, supplementing with PLP could reverse the metabolic profile of drug-resistant bacteria and effectively restore colistin’s bactericidal properties. Mechanistically, PLP was found to augment bacterial proton motive force by inhibiting the Kdp transport system, a bacterial K+ transport ATPase, thereby facilitating the binding of the positively charged colistin to the negatively charged bacterial membrane components. Furthermore, PLP supplementation triggers ferroptosis-like death by accumulating ferrous ions and inducing lipid peroxidation. These two modes of action collectively resensitize mcr-harboring Gram-negative bacteria to colistin therapy. Altogether, our study provides a novel metabolic-driven antibiotic sensitization strategy to tackle antibiotic resistance and identifies a potentially safe antibiotic synergist.https://doi.org/10.1038/s42003-025-07911-5
spellingShingle Tianqi Xu
Dan Fang
Fulei Li
Zhiqiang Wang
Yuan Liu
Vitamin B6 resensitizes mcr-carrying Gram-negative bacteria to colistin
Communications Biology
title Vitamin B6 resensitizes mcr-carrying Gram-negative bacteria to colistin
title_full Vitamin B6 resensitizes mcr-carrying Gram-negative bacteria to colistin
title_fullStr Vitamin B6 resensitizes mcr-carrying Gram-negative bacteria to colistin
title_full_unstemmed Vitamin B6 resensitizes mcr-carrying Gram-negative bacteria to colistin
title_short Vitamin B6 resensitizes mcr-carrying Gram-negative bacteria to colistin
title_sort vitamin b6 resensitizes mcr carrying gram negative bacteria to colistin
url https://doi.org/10.1038/s42003-025-07911-5
work_keys_str_mv AT tianqixu vitaminb6resensitizesmcrcarryinggramnegativebacteriatocolistin
AT danfang vitaminb6resensitizesmcrcarryinggramnegativebacteriatocolistin
AT fuleili vitaminb6resensitizesmcrcarryinggramnegativebacteriatocolistin
AT zhiqiangwang vitaminb6resensitizesmcrcarryinggramnegativebacteriatocolistin
AT yuanliu vitaminb6resensitizesmcrcarryinggramnegativebacteriatocolistin